Cover Image
市場調查報告書

TapImmune Inc.:產品平台分析

TapImmune Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 305694
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
TapImmune Inc.:產品平台分析 TapImmune Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月31日 內容資訊: 英文 28 Pages
簡介

TapImmune Inc.是針對腫瘤和感染疾病,開發基於胜肽及遺傳基因之免疫治療藥和疫苗的生物科技企業。該公司同時還推動前臨床用免疫療法計劃。

本報告提供TapImmune Inc. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃相關等資訊。

TapImmune Inc.的基本資料

  • TapImmune Inc.概要
  • 主要資訊
  • 企業資料

TapImmune Inc.:R&D概要

  • 主要的治療範圍

TapImmune Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

TapImmune Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅰ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

TapImmune Inc.:藥物簡介

  • TPIV-100
  • TPIV-110
  • TPIV-200
  • TPIV-120
  • TPIV-130
  • TPIV-300
  • TPIV-301

TapImmune Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型

TapImmune Inc.:最近的開發平台趨勢

TapImmune Inc.:暫停中的計劃

TapImmune Inc.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07531CDB

Summary

Global Markets Direct's, 'TapImmune Inc. - Product Pipeline Review - 2015', provides an overview of the TapImmune Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of TapImmune Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of TapImmune Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of TapImmune Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the TapImmune Inc.'s pipeline products

Reasons to buy

  • Evaluate TapImmune Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of TapImmune Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the TapImmune Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of TapImmune Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of TapImmune Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of TapImmune Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • TapImmune Inc. Snapshot
    • TapImmune Inc. Overview
    • Key Information
    • Key Facts
  • TapImmune Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • TapImmune Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • TapImmune Inc. - Pipeline Products Glance
    • TapImmune Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • TapImmune Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • TapImmune Inc. - Drug Profiles
    • TPIV-100
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-110
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-200
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-120
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-130
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-300
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TPIV-301
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • TapImmune Inc. - Pipeline Analysis
    • TapImmune Inc. - Pipeline Products by Target
    • TapImmune Inc. - Pipeline Products by Route of Administration
    • TapImmune Inc. - Pipeline Products by Molecule Type
  • TapImmune Inc. - Recent Pipeline Updates
  • TapImmune Inc. - Dormant Projects
  • TapImmune Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • TapImmune Inc., Key Information
  • TapImmune Inc., Key Facts
  • TapImmune Inc. - Pipeline by Indication, 2015
  • TapImmune Inc. - Pipeline by Stage of Development, 2015
  • TapImmune Inc. - Monotherapy Products in Pipeline, 2015
  • TapImmune Inc. - Phase I, 2015
  • TapImmune Inc. - Preclinical, 2015
  • TapImmune Inc. - Pipeline by Target, 2015
  • TapImmune Inc. - Pipeline by Route of Administration, 2015
  • TapImmune Inc. - Pipeline by Molecule Type, 2015
  • TapImmune Inc. - Recent Pipeline Updates, 2015
  • TapImmune Inc. - Dormant Developmental Projects,2015

List of Figures

  • TapImmune Inc. - Pipeline by Top 10 Indication, 2015
  • TapImmune Inc. - Pipeline by Stage of Development, 2015
  • TapImmune Inc. - Monotherapy Products in Pipeline, 2015
  • TapImmune Inc. - Pipeline by Top 10 Target, 2015
  • TapImmune Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top